title: Feline interferon-omega treatment on canine parvovirus infection.
abstract: Recombinant feline interferon-omega preparation (rFeIFN-omega, trade name: INTERCAT) showed good clinical efficacy on canine parvovirus infection both in an experimental trial with beagles, and in field trials.
authors.affiliation: Department of Microbiology, School of Medicine, Hokkaido University, Sapporo, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Minagawa
authors.forename: K
authors.initials: K
authors.lastname: Ishiwata
authors.forename: T
authors.initials: T
authors.lastname: Kajimoto
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D002415:Cats; D003967:Diarrhea / Q000150:complications / Q000188:drug therapy; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D007370:Interferon Type I / Q000627:therapeutic use*; D010322:Parvoviridae Infections / Q000150:complications / Q000188:drug therapy / Q000662:veterinary*; D017993:Parvovirus, Canine; D014839:Vomiting / Q000150:complications / Q000188:drug therapy
chemical_list: D000998:Antiviral Agents; D007370:Interferon Type I; C063743:interferon omega 1